2,3-diaminopyridine has been researched along with Innate Inflammatory Response in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bock, MG; Boyce, S; Chang, RS; Feng, DM; Freidinger, RM; Harrell, CM; Ivarsson, M; Kuduk, SD; Mason, G; Murphy, KL; Ng, C; Pettibone, DJ; Prueksaritanont, T; Ransom, RW; Reiss, D; Tang, C; Wai, JM | 1 |
1 other study(ies) available for 2,3-diaminopyridine and Innate Inflammatory Response
Article | Year |
---|---|
2,3-diaminopyridine bradykinin B1 receptor antagonists.
Topics: Aminopyridines; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bradykinin B1 Receptor Antagonists; Dogs; Half-Life; Inflammation; Pain Measurement; Rabbits; Rats; Species Specificity; Structure-Activity Relationship | 2004 |